Pulling SEC filings + quote and writing the call…

Progyny, Inc.
Next earnings Aug 5, 2026 · consensus $0.34 EPS, $356M rev
Last earnings +2.5% on 2026-05-07
Revenue grew 10.4% YoY.
Middling fundamentals and a rich price (~50% above fair value) leave little margin of safety — a wait-and-see.
Sources: SEC EDGAR (CIK 0001551306, latest 10-Q filed 2026-05-08) · EODHD · as of 6/26/2026, 7:31:51 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Progyny, Inc. shows $1.29B in FY2025 revenue (+10.4% YoY), a 4.5% net margin, and 11.3% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $501M | $787M | $1.09B | $1.17B | $1.29B |
| Gross profit | $112M | $167M | $239M | $253M | $304M |
| Operating income | $32.3M | $23.3M | $62.2M | $67.5M | $85.3M |
| Net income | $65.8M | $30.4M | $62.0M | $54.3M | $58.5M |
| Diluted EPS | $0.66 | $0.30 | $0.62 | $0.57 | $0.65 |
| Net margin | 13.1% | 3.9% | 5.7% | 4.7% | 4.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1047 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 8 sales
| 2026-06-17 | Clapp Geoffrey Chief Product Officer | Tax | 819.00 @ $26.60 | $21.8K |
| 2026-06-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Tax | 339.00 @ $24.99 | $8.47K |
| 2026-06-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sell | 1.92K @ $25.50 | $48.9K |
| 2026-06-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sell | 599.00 @ $25.50 | $15.3K |
| 2026-06-04 | Swartz Allison EVP, GC | Tax | 339.00 @ $24.99 | $8.47K |
| 2026-06-04 | Swartz Allison EVP, GC | Sell | 599.00 @ $25.08 | $15.0K |
| 2026-06-03 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Tax | 1.08K @ $25.12 | $27.2K |
| 2026-06-03 | Swartz Allison EVP, GC | Tax | 676.00 @ $25.12 | $17.0K |
| 2026-06-03 | Swartz Allison EVP, GC | Sell | 1.20K @ $25.02 | $30.0K |
| 2026-06-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Tax | 5.36K @ $25.12 | $135K |
| 2026-06-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Tax | 158.00 @ $26.20 | $4.14K |
| 2026-06-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sell | 279.00 @ $26.20 | $7.31K |